359 related articles for article (PubMed ID: 17656211)
1. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection.
Wasco MJ; Daignault S; Zhang Y; Kunju LP; Kinnaman M; Braun T; Lee CT; Shah RB
Urology; 2007 Jul; 70(1):69-74. PubMed ID: 17656211
[TBL] [Abstract][Full Text] [Related]
2. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
3. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
4. Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor.
Lee SE; Jeong IG; Ku JH; Kwak C; Lee E; Jeong JS
Urology; 2004 May; 63(5):873-7; discussion 877. PubMed ID: 15134968
[TBL] [Abstract][Full Text] [Related]
5. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases.
Wasco MJ; Daignault S; Bradley D; Shah RB
Hum Pathol; 2010 Feb; 41(2):163-71. PubMed ID: 19800100
[TBL] [Abstract][Full Text] [Related]
6. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital.
Shah RB; Montgomery JS; Montie JE; Kunju LP
Urol Oncol; 2013 Nov; 31(8):1650-5. PubMed ID: 22608543
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
8. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
Lughezzani G; Sun M; Jeldres C; Alasker A; Budäus L; Shariat SF; Latour M; Widmer H; Duclos A; Jolivet-Tremblay M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
Gupta A; Lotan Y; Bastian PJ; Palapattu GS; Karakiewicz PI; Raj GV; Schoenberg MP; Lerner SP; Sagalowsky AI; Shariat SF;
Urology; 2008 Feb; 71(2):302-7. PubMed ID: 18308108
[TBL] [Abstract][Full Text] [Related]
11. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
12. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.
Smaldone MC; Jacobs BL; Smaldone AM; Hrebinko RL
Urology; 2008 Sep; 72(3):613-6. PubMed ID: 18554696
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens.
Paner GP; Brown JG; Lapetino S; Nese N; Gupta R; Shen SS; Hansel DE; Amin MB
Am J Surg Pathol; 2010 Jun; 34(6):792-9. PubMed ID: 20421781
[TBL] [Abstract][Full Text] [Related]
15. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy.
Chen W; Luo JH; Hua WF; Zhou FJ; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):400-8. PubMed ID: 19155439
[TBL] [Abstract][Full Text] [Related]
17. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
[TBL] [Abstract][Full Text] [Related]
18. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
Cai T; Tiscione D; Verze P; Pomara G; Racioppi M; Nesi G; Barbareschi M; Brausi M; Gacci M; Luciani LG; Liguori G; Gontero P; Campodonico F; Simonato A; Boddi V; Di Stasi SM; Colombo R; Serretta V; Carmignani G; Malossini G; Altieri V; Carini M; Terrone C; Bassi P; Montorsi F; Ficarra V; Selli C; Mirone V; Bartoletti R
Urology; 2014 Nov; 84(5):1141-6. PubMed ID: 25239253
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
20. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
